Sleep Therapy Devices
The U.S. sleep therapy device market is growing with rising sleep apnea prevalence, increasing diagnosis rates, and wider adoption of home-based and connected treatment technologies. Our research provides actionable insights into market size, technology adoption, competitive developments, and investment opportunities across CPAP systems, BiPAP devices, sleep monitors, masks, and diagnostic equipment.
The U.S. Sleep Therapy Devices Market is positioned for robust growth, scaling from USD 6.28 billion in 2026 to USD 10.65 billion by 2032 at a 9.20% CAGR. Growth is anchored in widespread underdiagnosis of obstructive sleep apnea across more than 30 million Americans, rapid adoption of decentralized Type III/IV home sleep apnea testing (HSAT), and stringent Medicare capped-rental adherence rules that mandate cloud-connected positive airway pressure (PAP) platforms.
Read Report Details